Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-23

Clinical Trial Update: Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking History [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating olaparib with radiation therapy and cetuximab in advanced head and neck squamous cell carcinoma with heavy smoking history; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetuximab (cetuximab)
  • Olaparib (Olaparib)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 1 | Status: COMPLETED | Results posted: 2019-09-23